What is he best known for?
The fields of study he is best known for:
Erlend B. Smeland focuses on Lymphoma, Cancer research, Gene expression profiling, Molecular biology and Diffuse large B-cell lymphoma.
His study with Lymphoma involves better knowledge in Pathology.
His Pathology research includes elements of Internal medicine, Survival analysis and Oncology.
His Cancer research research is multidisciplinary, incorporating elements of Histone phosphorylation, Mutation, Amplicon and Germinal center, B cell.
Erlend B. Smeland has researched Molecular biology in several fields, including Cell cycle, Cyclin D1 and Haematopoiesis, Stem cell.
The Diffuse large B-cell lymphoma study combines topics in areas such as breakpoint cluster region and B-cell receptor.
His most cited work include:
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma (3077 citations)
- Stromal gene signatures in large-B-cell lymphomas (1240 citations)
- Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells (1189 citations)
What are the main themes of his work throughout his whole career to date?
Erlend B. Smeland mainly investigates Molecular biology, Cancer research, Lymphoma, Internal medicine and Pathology.
His research integrates issues of Haematopoiesis, Antibody, Bone marrow and Antigen in his study of Molecular biology.
His work carried out in the field of Cancer research brings together such families of science as Cell culture, Cancer, Germinal center, Diffuse large B-cell lymphoma and B-cell lymphoma.
The study incorporates disciplines such as Immunohistochemistry, B cell and Gene expression profiling in addition to Lymphoma.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Oncology.
His Pathology research integrates issues from Chromosome, Comparative genomic hybridization and Survival analysis.
He most often published in these fields:
- Molecular biology (42.79%)
- Cancer research (42.79%)
- Lymphoma (37.39%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (42.79%)
- Lymphoma (37.39%)
- Diffuse large B-cell lymphoma (20.72%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Lymphoma, Diffuse large B-cell lymphoma, B-cell lymphoma and Internal medicine.
Erlend B. Smeland has included themes like Cancer, Cytokine, Immune system, CD19 and B-Cell Non-Hodgkin Lymphoma in his Cancer research study.
Erlend B. Smeland interconnects Fluorescence in situ hybridization and EP300 in the investigation of issues within Lymphoma.
His work deals with themes such as Biopsy, Molecular classification, Double hit and Histopathology, which intersect with Diffuse large B-cell lymphoma.
His work in B-cell lymphoma addresses subjects such as Cell culture, which are connected to disciplines such as Cell cycle checkpoint, Downregulation and upregulation, Apoptosis, In vitro and Wild type.
His research in Internal medicine tackles topics such as Oncology which are related to areas like Gene expression, Primary Mediastinal Large B-Cell Lymphoma, Regulation of gene expression and Concordance.
Between 2017 and 2021, his most popular works were:
- Artesunate shows potent anti-tumor activity in B-cell lymphoma (32 citations)
- Artesunate shows potent anti-tumor activity in B-cell lymphoma (32 citations)
- TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma (31 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Lymphoma, Cancer research, Internal medicine, B-cell lymphoma and Mantle cell lymphoma.
The various areas that Erlend B. Smeland examines in his Lymphoma study include Concordance, Molecular classification and Histopathology.
His Cancer research research is multidisciplinary, relying on both Jurkat cells, Cancer, In vivo and Follicular dendritic cells.
His Internal medicine research incorporates themes from Cell culture, Unfolded protein response and Oncology.
His B-cell lymphoma study integrates concerns from other disciplines, such as T cell, Adoptive cell transfer, Chimeric antigen receptor and Antigen, CD19.
His Mantle cell lymphoma research includes themes of CD8, TIGIT, Cytokine, B-Cell Non-Hodgkin Lymphoma and Receptor expression.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
